Myriad Genetics Agrees To Market The Personalis ImmunoID Next Ultra-comprehensive Biomarker Discovery Platform To Its Partners Who Use The MyRisk Hereditary Cancer Test, BRACAnalysis CDx, and/or MyChoice CDx Cancer Tests
Benzinga Newsdesk - Nov 17, 2023, 4:05AM